Thus, VEGF-B excess due to overexpression could outcompete VEGF-A from VEGFR-1, and thereby result in increased VEGF-A/VEGFR-2 signalling and enhanced tumour angiogenesis, as has been demonstrated in adipose tissue30. The gene discussed is VEGFB; the disease is neoplasm.